These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23466826)

  • 21. Fixed combinations of neuroleptics with antidepressants: potential risks and estimation of use.
    Llerena A; Kiivet RA
    Br J Clin Pharmacol; 1994 Jun; 37(6):531-2. PubMed ID: 7917769
    [No Abstract]   [Full Text] [Related]  

  • 22. Nutrient-drug interactions.
    D'Arcy PF
    Adverse Drug React Toxicol Rev; 1995; 14(4):233-54. PubMed ID: 8845456
    [No Abstract]   [Full Text] [Related]  

  • 23. Azithromycin-warfarin interaction: are we fishing with a red herring?
    Eschenauer G; Collins CD; Regal RE
    Pharmacotherapy; 2005 Apr; 25(4):630-1; discussion 631. PubMed ID: 15977924
    [No Abstract]   [Full Text] [Related]  

  • 24. [Monitoring mood regulating drugs in bipolar disorder].
    Millet B; Vanelle JM
    Encephale; 2006 Sep; 32 Pt 2():S536-41. PubMed ID: 17099570
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.
    Daly AK
    Arch Toxicol; 2013 Mar; 87(3):407-20. PubMed ID: 23376975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting the significance of warfarin protein-binding displacement interactions.
    Sands CD; Chan ES; Welty TE
    Ann Pharmacother; 2002 Oct; 36(10):1642-4. PubMed ID: 12369572
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug interactions in alcoholic patients.
    Marco LA; Randels PM
    Hillside J Clin Psychiatry; 1981; 3(1):27-44. PubMed ID: 6152587
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible interaction between gatifloxacin and warfarin.
    Artymowicz RJ; Cino BJ; Rossi JG; Walker JL; Moore S
    Am J Health Syst Pharm; 2002 Jun; 59(12):1205-6. PubMed ID: 12073864
    [No Abstract]   [Full Text] [Related]  

  • 29. Avoiding overanticoagulation: pharmacogenomics or pragmatism?
    Baglin T
    Thromb Haemost; 2001 May; 85(5):945-6. PubMed ID: 11372698
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of advantages and disadvantages of agents used for therapeutic anticoagulation.
    Berger PB
    Dis Mon; 2012 Aug; 58(8):462-8. PubMed ID: 22818560
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adverse events of antipsychotics, antidepressants, mood stabilizers, antiepileptics, and psychostimulants].
    Owashi T; Kamijima K
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():279-85. PubMed ID: 23156521
    [No Abstract]   [Full Text] [Related]  

  • 32. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Zealand Committee on Adverse Drug Reactions: seventh annual report.
    N Z Med J; 1972 Nov; 76(486):357-64. PubMed ID: 4510143
    [No Abstract]   [Full Text] [Related]  

  • 34. Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases
.
    Shibata S; Takahashi H; Baba A; Takeshita K; Atsuda K; Matsubara H; Echizen H
    Int J Clin Pharmacol Ther; 2017 May; 55(5):449-452. PubMed ID: 28157069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs and pregnancy.
    Murphy JF
    Ir Med J; 1984 Feb; 77(2):52-6. PubMed ID: 6370905
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015.
    Baftiu A; Feet SA; Larsson PG; Burns ML; Henning O; Sætre E; Molden E; Granas AG; Johannessen SI; Landmark CJ
    Epilepsy Res; 2018 Jan; 139():35-42. PubMed ID: 29175562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytonadione therapy in a multiple-drug overdose involving warfarin.
    Bates D; Mintz M
    Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between warfarin and oral terbinafine. Manufacturer does not agree that interaction was with terbinafine.
    Gantmacher J; Mills-Bomford J; Williams T
    BMJ; 1998 Jul; 317(7152):205; author reply 205. PubMed ID: 9665914
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin.
    Bannister SJ; Houser VP; Hulse JD; Kisicki JC; Rasmussen JG
    Acta Psychiatr Scand Suppl; 1989; 350():102-6. PubMed ID: 2530759
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients.
    Ahmed A; Schriever C; Britt N; Yager J; Amin R; McGuey L; Patel N
    Ann Hepatol; 2019; 18(4):601-606. PubMed ID: 31078440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.